Prosthetic Valve Endocarditis, A Case Report: Challenges and Advances
Main Article Content
Abstract
Infective endocarditis on valve prostheses accounts for 10-30% of all cases of endocarditis, with an in-hospital mortality of 20-40%. It is present in approximately 1-6%4 of patients with valve prostheses, with an incidence of 0.3-1.2% of patients per year. We present the case of a patient who underwent his third sternotomy secondary to acute heart failure due to dysfunction of the mechanical prosthesis, rupture of the annulus and severe paravalvular leak.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-93.
II. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Pare C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354-61.
III. Ramos C, Gonzalez M, Lopez M, Obando J, Nafeh M, Hernandez M. Infective endocarditis in prosthetic valves. CorHealth 2020;12(2):146-154.
IV. Habib G, Thuny F, Avierinos JF. Prosthetic valve endocarditis: Current approach and therapeutic options. Prog Cardiovasc Dis. 2008;50:274-81.
V. Mihos CG, Capoulade R, Yucel E, Picard MH, Santana O. Surgical versus medical therapy for prosthetic valve endocarditis: A meta-analysis of 32 studies. Ann Thorac Surg. 2017;103(3):991-1004.
VI. Nonaka M, Kusuhara T, An K, Nakatsuka D, Sekine Y, Iwakura A, Yamanaka K. Comparison between early and late prosthetic valve endocarditis: clinical characteristics and outcomes. J Heart Valve Dis. 2013;22(4):567-74.
VII. Olmos C, Vilacosta I, López J, Sarriá C, Ferrera C, San Román JC. Update on prosthetic endocarditis. Cir Cardiov. 2017;24(1):33-40.
VIII. López J, Revilla A, Vilacosta I, Villacorta E, Gonzalez-Juanatey C, Gomez I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28:760-5.
IX. Sohail MR, Gray AL, Baddour LM, Tleyjeh IM, Virk A. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009;15:387-94.
X. Guío L, Sarriá C, de las Cuevas C, Gamallo C, Duarte J. Chronic prosthetic valve endocarditis due to Propionibacterium acnes: An unexpected cause of prosthetic valve dysfunction. Rev Esp Cardiol. 2009;62:167-77.
XI. Pozo E, Olmos C, de Agustín JA, Jiménez-Ballvé A, Pérez de Isla L, Macaya C. Advances in the diagnostic imaging of left infective endocarditis. Cir Cardiov. 2017;24(4):228-35.
XII. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf C, et al. Infective endocarditis in Europe: Lessons from the Euro heart survey. Heart. 2005;91:571-5.
XIII. Andrade MO, Raffoul GE, Macedo MT, Silva CN, Teixeira MA, Pontes SJ, et al. Experience of treatment of prosthetic valve endocarditis: a retrospective single-center cross-sectional study. Sao Paulo Med J. 2018;136(4):287-91.
XIV. Gordon SM, Serkey JM, Longworth DL, Lytle BW, Cosgrove DM. Early onset prosthetic valve endocarditis: The Cleveland Clinic experience 1992-1997. Ann Thorac Surg. 2000;69:1388-92.
XV. Abramczuk E, Stępińska J, Hryniewiecki T. Twenty-Year Experience in the Diagnosis and Treatment of Infective Endocarditis. PLoSOne [Internet]. 2015 [cited 18 Apr 2020];10(7):e0134021. Available from: http://doi.org/10.1371/journal.pone.0134021
XVI. Luk A, Kim ML, Ross HJ, Rao V, David TE, Butany J. Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature. Malays J Pathol. 2014;36(2):71-81.
XVII. Vilacosta I, Olmos C, de Agustín A, López J, Islas F, Sarriá C, et al. The diagnostic ability of echocardiography for infective endocarditis and its associated complications. Expert Rev Cardiovasc Ther. 2015;13(11):1225-36.
XVIII. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA. 2011;306:2239-47.